Esaote Group to Unveil Revolutionary Cardiac Imaging Technology at ESC 2025 in Madrid
Esaote Group's Impactful Innovations at ESC 2025
The Esaote Group, a prominent leader in medical imaging technology, is set to showcase its innovative solutions at the European Society of Cardiology (ESC) 2025 Congress in Madrid from August 29 to September 1. The event will take place at IFEMA MADRID, where Esaote will exhibit its latest advancements in cardiovascular imaging designed to enhance diagnostic precision and streamline clinical workflows.
Introducing MyLab™C30 cardio
One of the standout exhibits will be the unveiling of the MyLab™C30 cardio, a portable ultrasound device meticulously crafted for cardiology settings. This cutting-edge machine features the largest touchscreen in its class, coupled with an intuitive interface and advanced AI-driven tools that significantly reduce scanning time while ensuring reliable diagnoses. This device is ideal for both emergency and routine environments, backed by a powerful long-lasting battery that supports its robust performance even in challenging scenarios.
HeartScan Assistant: AI Power for Cardiology
Esaote will also introduce the HeartScan Assistant, an innovative AI-driven feature designed to enhance the process of transthoracic echocardiography. This tool offers healthcare providers real-time AI insights on image classification and quality, dramatically streamlining the daily practices of cardiologists. Particularly beneficial for emergency professionals and those who are less experienced, this tool aims to simplify the diagnostic process, which can often be complex and time-consuming.
Hyperdoppler Techniques Presentation
On Saturday, August 30, Esaote will host an in-depth presentation at its booth from 12:00 PM to 1:30 PM, focusing on Hyperdoppler techniques. This session will explore their clinical applications and how force distribution analysis can identify dilated or dysfunctional hearts, while also monitoring the impact of resynchronization therapies in heart failure patients.
Advancements in Healthcare IT
In addition to imaging technology, Esaote’s IT division, Ebit, will present the latest version of its Suitestensa CVIS PACS platform. This system is designed for both outpatient and interventional cardiology, incorporating AI tools such as fAInd to assist in clinical decision-making and ZEfiRO for intelligent workflow orchestration. Furthermore, it provides seamless integration with advanced tools like CAAS Qardia.
CAAS Qardia Version 2.2 Highlights
An exciting feature is the upcoming release of CAAS Qardia, an echocardiography suite developed by Pie Medical Imaging, which is a part of the Esaote Group. The new version 2.2 is equipped with the Qardia View Classifier, an AI assistant that aids in selecting optimal images for standardized measurements, thereby minimizing manual selection and expediting the navigation through image sets. Critical ecometrics, such as myocardial strain and cardiac dimensions, are now automated, streamlining the overall process and maximizing efficiency.
Commitment to Cardiovascular Diagnostics
Through continuous innovation, clinical collaboration, and ongoing investment in R&D, the Esaote Group reaffirms its dedication to advancing cardiovascular diagnostics. This commitment is set against a backdrop of growth, with the company employing around 1,300 staff members worldwide—half based in Italy—and maintaining production and research facilities in Genoa and Florence, as well as the Netherlands.
Overall, the participation of Esaote at ESC 2025 symbolizes a significant leap forward in the field of cardiac care and technology, promising to enhance the overall quality of healthcare services and patient outcomes.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.